Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

OREXO US, INC. — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report (No Activity)

OREXO US, INC.

via CONNECT 4 STRATEGIES, LLC

2nd Quarter (Apr 1 - June 30) · 2025Posted Jul 21, 2025Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: OREXO US, INC.
Description: Pharmaceutical Company
Location: New Jersey · United States of America

Registrant

Firm: CONNECT 4 STRATEGIES, LLC
Description: Strategic Consulting
Location: White Stone, Virginia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.